WEHI 1, WEHI 2, Biolabs 360 ,Leiden Data 4 from 4 on Covid Treatment?, page-31

Its the decline that occurs between trialing and results that has the PAA chart looking poor , lets hope the Leiden data is well publicised and not just an ASX announcement ,,,which is the minimum regulatory requirement and not promotion or marketing ...... the irony is the SP is currently lower than prior to the first WEHI 2nd WEHI and Biolabs positive results,,, so no Covid Treatment advances made are reflected in the SP... Obviously we all know the big decline was from the Elanco Deal not being finalised ,,
Just watched the Marc Pelligrini interview again "Absolutely Remarkable" well worth another viewing